71
Participants
Start Date
January 17, 2022
Primary Completion Date
April 30, 2026
Study Completion Date
April 30, 2026
ELX/TEZ/IVA
Fixed-dose combination granules or tablets for oral administration.
IVA
Granules or tablets for oral administration.
UPMC Children's Hospital of Pittsburgh, Pittsburgh
NC TraCS Institute - CTRC University of North Carolina at Chapel Hill, Chapel Hill
Riley Hospital for Children at Indiana University Health, Indianapolis
Children's Respiratory and Critical Care Specialists, P.A., Children's Hospitals and Clinics of Minnesota, Minneapolis
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Washington University School of Medicine / St. Louis Children's Hospital, St Louis
The Children's Mercy Hospital, Kansas City
Children's Hospital of Colorado, Aurora
Banner University of Arizona Medical Center, Tucson
Stanford University, Palo Alto
Oregon Health & Science University, Portland
Seattle Children's Hospital, Seattle
Boston Children's Hospital, Boston
Telethon Kids Institute, Nedlands
The Royal Children's Hospital, Parkville
Queensland Children's Hospital, South Brisbane
The Hospital for Sick Children, Toronto
British Columbia Children's Hospital, Vancouver
Charite Paediatric Pulmonology Department, Berlin
Universitatsklinikum Essen (AoR), Kinderklinik III, Abt. fur Pneumologie, Essen
Alder Hey Children's NHS Foundation Trust, Liverpool
Royal Brompton Hospital, London
Vertex Pharmaceuticals Incorporated
INDUSTRY